{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T14:10:49Z","timestamp":1765289449182,"version":"3.46.0"},"reference-count":75,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Clinics of North America"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.ucl.2025.09.002","type":"journal-article","created":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T03:53:45Z","timestamp":1761364425000},"page":"33-44","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Advances in Prostate Biopsy"],"prefix":"10.1016","volume":"53","author":[{"given":"Jillian M.","family":"Egan Kelly","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Badar M.","family":"Mian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ucl.2025.09.002_bib1","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S0022-5347(17)38663-9","article-title":"Ultrasound guided transrectal core biopsies of the palpably abnormal prostate","volume":"142","author":"Hodge","year":"1989","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.ucl.2025.09.002_bib2","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0022-5347(17)38664-0","article-title":"Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate","volume":"142","author":"Hodge","year":"1989","journal-title":"J Urol"},{"key":"10.1016\/j.ucl.2025.09.002_bib3","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0090-4295(95)96168-2","article-title":"Make the most out of siex systematic sextant biopsy","volume":"45","author":"Stamey","year":"1995","journal-title":"Urology"},{"issue":"1","key":"10.1016\/j.ucl.2025.09.002_bib4","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0022-5347(05)64051-7","article-title":"Extended peripheral zone biopsy schemes increase cancer detection rates and minimize variance in prostate specific antigen and age related cancer rates: results of a community multi-practice study","volume":"169","author":"Presti","year":"2003","journal-title":"J Urol"},{"issue":"8","key":"10.1016\/j.ucl.2025.09.002_bib5","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1002\/1097-0142(20001015)89:8<1800::AID-CNCR21>3.0.CO;2-D","article-title":"Detailed mapping of prostate carcinoma foci","volume":"89","author":"Chen","year":"2000","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.ucl.2025.09.002_bib6","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0022-5347(05)67993-1","article-title":"A comparative analysis of sextant and an extended 11-core multisite directed biopsy strategy","volume":"163","author":"Babaian","year":"2000","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.ucl.2025.09.002_bib7","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S0022-5347(05)64053-0","article-title":"Extended prostate needle biopsy improves concordance of gleason grading between prostate needle biopsy and radical prostatectomy","volume":"169","author":"San Francisco","year":"2003","journal-title":"J Urol"},{"issue":"2","key":"10.1016\/j.ucl.2025.09.002_bib8","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.urology.2005.08.018","article-title":"Role of prostate biopsy schemes in accurate prediction of Gleason scores","volume":"67","author":"Mian","year":"2006","journal-title":"Urology"},{"issue":"2","key":"10.1016\/j.ucl.2025.09.002_bib9","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0022-5347(05)00211-9","article-title":"Saturation technique does not improve cancer detection as an initial prostate biopsy strategy","volume":"175","author":"Jones","year":"2006","journal-title":"J Urol"},{"issue":"5","key":"10.1016\/j.ucl.2025.09.002_bib10","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1016\/S0022-5347(05)00957-2","article-title":"Diagnostic value of systematic biopsy methods in the investigation of prostate cancer: a systematic review","volume":"175","author":"Eichler","year":"2006","journal-title":"J Urol"},{"issue":"5","key":"10.1016\/j.ucl.2025.09.002_bib11","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.urology.2010.05.022","article-title":"Enhanced transrectal ultrasound modalities in the diagnosis of prostate cancer","volume":"76","author":"Trabulsi","year":"2010","journal-title":"Urology"},{"issue":"3","key":"10.1016\/j.ucl.2025.09.002_bib12","doi-asserted-by":"crossref","first-page":"623","DOI":"10.2214\/ajr.174.3.1740623","article-title":"Using gray-scale and color and power Doppler sonography to detect prostatic cancer","volume":"174","author":"Halpern","year":"2000","journal-title":"AJR Am J Roentgenol"},{"issue":"3","key":"10.1016\/j.ucl.2025.09.002_bib23","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.euo.2018.10.001","article-title":"Comparison of the diagnostic accuracy of micro-ultrasound and magnetic resonance imaging\/ultrasound fusion targeted biopsies for the diagnosis of clinically significant prostate cancer","volume":"2","author":"Lughezzani","year":"2019","journal-title":"Eur Urol Oncol"},{"issue":"2","key":"10.1016\/j.ucl.2025.09.002_bib20","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/bco2.59","article-title":"A multi-institutional randomized controlled trial comparing first-generation transrectal high-resolution micro-ultrasound with conventional frequency transrectal ultrasound for prostate biopsy","volume":"2","author":"Pavlovich","year":"2021","journal-title":"BJUI Compass"},{"issue":"2","key":"10.1016\/j.ucl.2025.09.002_bib29","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/bju.14759","article-title":"Biparametric vs multiparametric prostate magnetic resonance imaging for the detection of prostate cancer in treatment-naive patients: a diagnostic test accuracy systematic review and meta-analysis","volume":"124","author":"Alabousi","year":"2019","journal-title":"BJU Int"},{"issue":"3","key":"10.1016\/j.ucl.2025.09.002_bib30","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1038\/s41391-020-00298-w","article-title":"A systematic review and meta-analysis of the diagnostic accuracy of biparametric prostate MRI for prostate cancer in men at risk","volume":"24","author":"Bass","year":"2021","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"2","key":"10.1016\/j.ucl.2025.09.002_bib31","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.eururo.2024.09.035","article-title":"Evaluating biparametric versus multiparametric magnetic resonance imaging for diagnosing clinically significant prostate cancer: an international, paired, noninferiority, confirmatory observer study","volume":"87","author":"Twilt","year":"2025","journal-title":"Eur Urol"},{"issue":"7","key":"10.1016\/j.ucl.2025.09.002_bib32","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1007\/s00345-020-03490-8","article-title":"Detection of prostate cancer with (18)F-DCFPyL PET\/CT compared to final histopathology of radical prostatectomy specimens: is PSMA-targeted biopsy feasible? The DeTeCT trial","volume":"39","author":"Bodar","year":"2021","journal-title":"World J Urol"},{"issue":"8","key":"10.1016\/j.ucl.2025.09.002_bib33","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1007\/s00259-021-05636-1","article-title":"Dual-tracer PET\/CT-targeted, mpMRI-targeted, systematic biopsy, and combined biopsy for the diagnosis of prostate cancer: a pilot study","volume":"49","author":"Qiu","year":"2022","journal-title":"Eur J Nucl Med Mol Imag"},{"issue":"2","key":"10.1016\/j.ucl.2025.09.002_bib13","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.juro.2007.03.107","article-title":"Comparison of contrast enhanced color Doppler targeted biopsy to conventional systematic biopsy: impact on Gleason score","volume":"178","author":"Mitterberger","year":"2007","journal-title":"J Urol"},{"issue":"14","key":"10.1016\/j.ucl.2025.09.002_bib14","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1002\/pros.20639","article-title":"A prospective randomized trial comparing contrast-enhanced targeted versus systematic ultrasound guided biopsies: impact on prostate cancer detection","volume":"67","author":"Mitterberger","year":"2007","journal-title":"Prostate"},{"issue":"1","key":"10.1016\/j.ucl.2025.09.002_bib15","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1148\/radiol.2251011938","article-title":"Prostate: high-frequency Doppler US imaging for cancer detection","volume":"225","author":"Halpern","year":"2002","journal-title":"Radiology"},{"issue":"6","key":"10.1016\/j.ucl.2025.09.002_bib16","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1016\/j.juro.2007.08.022","article-title":"Contrast enhanced ultrasound flash replenishment method for directed prostate biopsies","volume":"178","author":"Linden","year":"2007","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.ucl.2025.09.002_bib17","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/01.ju.0000162043.72294.4a","article-title":"Initial experiences with real-time elastography guided biopsies of the prostate","volume":"174","author":"Konig","year":"2005","journal-title":"J Urol"},{"issue":"2","key":"10.1016\/j.ucl.2025.09.002_bib18","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.ejrad.2007.03.032","article-title":"Sonoelastography of the prostate: comparison with systematic biopsy findings in 492 patients","volume":"65","author":"Pallwein","year":"2008","journal-title":"Eur J Radiol"},{"issue":"6","key":"10.1016\/j.ucl.2025.09.002_bib19","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.urology.2007.07.067","article-title":"Targeted biopsy of the prostate: the impact of color Doppler imaging and elastography on prostate cancer detection and Gleason score","volume":"70","author":"Nelson","year":"2007","journal-title":"Urology"},{"issue":"2","key":"10.1016\/j.ucl.2025.09.002_bib21","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.juro.2015.12.093","article-title":"Assessing cancer risk on novel 29 MHz micro-ultrasound images of the prostate: creation of the micro-ultrasound protocol for prostate risk identification","volume":"196","author":"Ghai","year":"2016","journal-title":"J Urol"},{"key":"10.1016\/j.ucl.2025.09.002_bib22","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.3389\/fonc.2019.01368","article-title":"Micro-ultrasound imaging for accuracy of diagnosis in clinically significant prostate cancer: a meta-analysis","volume":"9","author":"Zhang","year":"2019","journal-title":"Front Oncol"},{"key":"10.1016\/j.ucl.2025.09.002_bib24","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ejrad.2017.02.044","article-title":"Magnetic resonance imaging of the prostate at 1.5 versus 3.0T: a prospective comparison study of image quality","volume":"90","author":"Ullrich","year":"2017","journal-title":"Eur J Radiol"},{"issue":"10071","key":"10.1016\/j.ucl.2025.09.002_bib25","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0140-6736(16)32401-1","article-title":"Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study","volume":"389","author":"Ahmed","year":"2017","journal-title":"Lancet"},{"issue":"19","key":"10.1016\/j.ucl.2025.09.002_bib26","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1056\/NEJMoa1801993","article-title":"MRI-targeted or standard biopsy for prostate-cancer diagnosis","volume":"378","author":"Kasivisvanathan","year":"2018","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.ucl.2025.09.002_bib27","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S1470-2045(18)30569-2","article-title":"Use of prostate systematic and targeted biopsy on the basis of multiparametric MRI in biopsy-naive patients (MRI-FIRST): a prospective, multicentre, paired diagnostic study","volume":"20","author":"Rouviere","year":"2019","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.ucl.2025.09.002_bib28","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.eururo.2015.08.038","article-title":"Synopsis of the PI-RADS v2 guidelines for multiparametric prostate magnetic resonance imaging and recommendations for use","volume":"69","author":"Barentsz","year":"2016","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.ucl.2025.09.002_bib34","doi-asserted-by":"crossref","first-page":"274","DOI":"10.4081\/aiua.2022.3.274","article-title":"Targeted prostate biopsy: 68Ga-PSMA PET\/CT vs. mpMRI in the diagnosis of prostate cancer","volume":"94","author":"Pepe","year":"2022","journal-title":"Arch Ital Urol Androl"},{"issue":"10","key":"10.1016\/j.ucl.2025.09.002_bib35","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.1007\/s00259-021-05261-y","article-title":"Diagnostic performance of (68)Ga-PSMA-11 PET\/MRI-guided biopsy in patients with suspected prostate cancer: a prospective single-center study","volume":"48","author":"Ferraro","year":"2021","journal-title":"Eur J Nucl Med Mol Imag"},{"issue":"10","key":"10.1016\/j.ucl.2025.09.002_bib36","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1056\/NEJMoa1910038","article-title":"MRI-targeted, systematic, and combined biopsy for prostate cancer diagnosis","volume":"382","author":"Ahdoot","year":"2020","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.ucl.2025.09.002_bib37","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41391-024-00827-x","article-title":"Prostate cancer detection and complications of MRI-targeted prostate biopsy using cognitive registration, software-assisted image fusion or in-bore guidance: a systematic review and meta-analysis of comparative studies","volume":"28","author":"Falagario","year":"2025","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.ucl.2025.09.002_bib38","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.urology.2018.06.011","article-title":"Cognitive versus software fusion for MRI-targeted biopsy: experience before and after implementation of fusion","volume":"119","author":"Monda","year":"2018","journal-title":"Urology"},{"key":"10.1016\/j.ucl.2025.09.002_bib39","unstructured":"Mian BM. Fusion or cognitive ultrasound-guided biopsy to detect prostate cancer (FOCUS-PC). 2025;NCT06517901. Available at: https:\/\/clinicaltrials.gov\/study\/NCT06517901 (Accessed 30 August 2025)."},{"issue":"3","key":"10.1016\/j.ucl.2025.09.002_bib40","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.eururo.2016.08.004","article-title":"Complications after systematic, random, and image-guided prostate biopsy","volume":"71","author":"Borghesi","year":"2017","journal-title":"Eur Urol"},{"issue":"2","key":"10.1016\/j.ucl.2025.09.002_bib41","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.juro.2017.01.103","article-title":"An update of the American Urological Association white paper on the prevention and treatment of the more common complications related to prostate biopsy","volume":"198","author":"Liss","year":"2017","journal-title":"J Urol"},{"issue":"5","key":"10.1016\/j.ucl.2025.09.002_bib42","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1016\/j.juro.2011.06.057","article-title":"Complications after prostate biopsy: data from SEER-medicare","volume":"186","author":"Loeb","year":"2011","journal-title":"J Urol"},{"key":"10.1016\/j.ucl.2025.09.002_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.euros.2024.06.015","article-title":"Risk factors for infection after transrectal prostate biopsy: a population-based register study","volume":"67","author":"Ortegren","year":"2024","journal-title":"Eur Urol Open Sci"},{"key":"10.1016\/j.ucl.2025.09.002_bib44","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.urology.2016.12.011","article-title":"Prostate biopsy-related infection: a systematic review of risk factors, prevention strategies, and management approaches","volume":"104","author":"Roberts","year":"2017","journal-title":"Urology"},{"issue":"5","key":"10.1016\/j.ucl.2025.09.002_bib45","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1111\/bju.13402","article-title":"The role of targeted prophylactic antimicrobial therapy before transrectal ultrasonography-guided prostate biopsy in reducing infection rates: a systematic review","volume":"117","author":"Cussans","year":"2016","journal-title":"BJU Int"},{"issue":"4","key":"10.1016\/j.ucl.2025.09.002_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.urolonc.2017.12.005","article-title":"Targeted antimicrobial prophylaxis for transrectal ultrasound-guided prostate biopsy during active surveillance: effect on hospitalization","volume":"36","author":"Cheung","year":"2018","journal-title":"Urol Oncol"},{"issue":"2","key":"10.1016\/j.ucl.2025.09.002_bib47","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.juro.2015.03.110","article-title":"Comparative effectiveness of targeted vs empirical antibiotic prophylaxis to prevent sepsis from transrectal prostate biopsy: a retrospective analysis","volume":"194","author":"Liss","year":"2015","journal-title":"J Urol"},{"issue":"2","key":"10.1016\/j.ucl.2025.09.002_bib48","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.juro.2018.03.078","article-title":"Targeted antimicrobial prophylaxis does not always prevent sepsis after transrectal prostate biopsy","volume":"200","author":"Jiang","year":"2018","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.ucl.2025.09.002_bib49","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.euf.2018.06.016","article-title":"Effect of augmented antimicrobial prophylaxis and rectal swab culture-guided targeted prophylaxis on the risk of sepsis following transrectal prostate biopsy","volume":"6","author":"Hadjipavlou","year":"2020","journal-title":"Eur Urol Focus"},{"issue":"2","key":"10.1016\/j.ucl.2025.09.002_bib50","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/bju.13982","article-title":"Evaluation of a needle disinfectant technique to reduce infection-related hospitalisation after transrectal prostate biopsy","volume":"121","author":"Auffenberg","year":"2018","journal-title":"BJU Int"},{"issue":"4","key":"10.1016\/j.ucl.2025.09.002_bib51","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/j.juro.2012.09.121","article-title":"A prospective randomized trial of povidone-iodine prophylactic cleansing of the rectum before transrectal ultrasound guided prostate biopsy","volume":"189","author":"Abughosh","year":"2013","journal-title":"J Urol"},{"issue":"6","key":"10.1016\/j.ucl.2025.09.002_bib52","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1097\/JU.0000000000002910","article-title":"Effectiveness of intrarectal povidone-iodine cleansing plus formalin disinfection of the needle tip in decreasing infectious complications after transrectal prostate biopsy: a randomized controlled trial","volume":"208","author":"Pontes-Junior","year":"2022","journal-title":"J Urol"},{"issue":"3","key":"10.1016\/j.ucl.2025.09.002_bib53","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1097\/JU.0000000000001399","article-title":"Nonantibiotic strategies for the prevention of infectious complications following prostate biopsy: a systematic review and meta-analysis","volume":"205","author":"Pradere","year":"2021","journal-title":"J Urol"},{"key":"10.1016\/j.ucl.2025.09.002_bib54","unstructured":"Bonkat G. EAU Guidelines: Urological Infections. 2025. Available at: https:\/\/uroweb.org\/guidelines\/prostate-cancer\/chapter\/diagnostic-evaluation (Accessed 30 August 2025)."},{"key":"10.1016\/j.ucl.2025.09.002_bib55","doi-asserted-by":"crossref","DOI":"10.1177\/17562872221105019","article-title":"Schema and cancer detection rates for transperineal prostate biopsy templates: a review","volume":"14","author":"Sidana","year":"2022","journal-title":"Ther Adv Urol"},{"issue":"5","key":"10.1016\/j.ucl.2025.09.002_bib56","doi-asserted-by":"crossref","first-page":"191.e1","DOI":"10.1016\/j.urolonc.2021.11.026","article-title":"How many cores are enough? Optimizing the transperineal prostate biopsy template","volume":"40","author":"Schaufler","year":"2022","journal-title":"Urol Oncol"},{"issue":"12","key":"10.1016\/j.ucl.2025.09.002_bib57","doi-asserted-by":"crossref","first-page":"528.e15","DOI":"10.1016\/j.urolonc.2018.09.013","article-title":"Free-hand transperineal prostate biopsy provides acceptable cancer detection and minimizes risk of infection: evolving experience with a 10-sector template","volume":"36","author":"Ristau","year":"2018","journal-title":"Urol Oncol"},{"issue":"1","key":"10.1016\/j.ucl.2025.09.002_bib58","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/s41391-020-0204-8","article-title":"\u201cTREXIT 2020\u201d: why the time to abandon transrectal prostate biopsy starts now","volume":"23","author":"Grummet","year":"2020","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.ucl.2025.09.002_bib75","unstructured":"Available at: https:\/\/musicurology.com\/programs\/prostate\/transperinealbiopsy (Accessed 30 August 2025)."},{"issue":"2","key":"10.1016\/j.ucl.2025.09.002_bib59","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/s41391-023-00729-4","article-title":"Transperineal magnetic resonance imaging targeted biopsy versus transrectal route in the detection of prostate cancer: a systematic review and meta-analysis","volume":"27","author":"Wu","year":"2024","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"6","key":"10.1016\/j.ucl.2025.09.002_bib60","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.euo.2020.12.012","article-title":"Magnetic resonance imaging\/ultrasound fusion-guided transperineal versus magnetic resonance imaging\/ultrasound fusion-guided transrectal prostate Biopsy-A systematic review","volume":"4","author":"Rai","year":"2021","journal-title":"Eur Urol Oncol"},{"issue":"4","key":"10.1016\/j.ucl.2025.09.002_bib61","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1097\/JU.0000000000002802","article-title":"The detection of prostate cancer with magnetic resonance imaging-targeted prostate biopsies is superior with the transperineal vs the transrectal approach. A European Association of urology-young academic urologists prostate cancer working group multi-ins","volume":"208","author":"Zattoni","year":"2022","journal-title":"J Urol"},{"issue":"8","key":"10.1016\/j.ucl.2025.09.002_bib62","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1007\/s00345-016-1985-1","article-title":"Zero hospital admissions for infection after 577 transperineal prostate biopsies using single-dose cephazolin prophylaxis","volume":"35","author":"Pepdjonovic","year":"2017","journal-title":"World J Urol"},{"issue":"1","key":"10.1016\/j.ucl.2025.09.002_bib63","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/bju.12282","article-title":"Indications, results and safety profile of transperineal sector biopsies (TPSB) of the prostate: a single centre experience of 634 cases","volume":"114","author":"Vyas","year":"2014","journal-title":"BJU Int"},{"issue":"1","key":"10.1016\/j.ucl.2025.09.002_bib64","doi-asserted-by":"crossref","DOI":"10.1186\/s12957-019-1573-0","article-title":"Transperineal versus transrectal prostate biopsy in the diagnosis of prostate cancer: a systematic review and meta-analysis","volume":"17","author":"Xiang","year":"2019","journal-title":"World J Surg Oncol"},{"issue":"3","key":"10.1016\/j.ucl.2025.09.002_bib65","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/bju.15337","article-title":"Local anaesthetic transperineal (LATP) prostate biopsy using a probe-mounted transperineal access system: a multicentre prospective outcome analysis","volume":"128","author":"Lopez","year":"2021","journal-title":"BJU Int"},{"issue":"6","key":"10.1016\/j.ucl.2025.09.002_bib66","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1089\/end.2019.0170","article-title":"A retrospective comparison of transrectal and transperineal prostate biopsies: experience of a single surgeon","volume":"33","author":"Young","year":"2019","journal-title":"J Endourol"},{"issue":"8","key":"10.1016\/j.ucl.2025.09.002_bib67","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1017\/S0950268815002885","article-title":"The global burden of major infectious complications following prostate biopsy","volume":"144","author":"Bennett","year":"2016","journal-title":"Epidemiol Infect"},{"issue":"14","key":"10.1016\/j.ucl.2025.09.002_bib68","doi-asserted-by":"crossref","first-page":"23322","DOI":"10.18632\/oncotarget.15056","article-title":"Comparison between transrectal and transperineal prostate biopsy for detection of prostate cancer: a meta-analysis and trial sequential analysis","volume":"8","author":"Xue","year":"2017","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.ucl.2025.09.002_bib69","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/s41391-021-00352-1","article-title":"Rationale and protocol for randomized study of transrectal and transperineal prostate biopsy efficacy and complications (ProBE-PC study)","volume":"24","author":"Mian","year":"2021","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"1","key":"10.1016\/j.ucl.2025.09.002_bib70","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/JU.0000000000003979","article-title":"Clinically significant prostate cancer detection following transrectal and transperineal biopsy: results of the prostate biopsy efficacy and complications randomized clinical trial","volume":"212","author":"Mian","year":"2024","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.ucl.2025.09.002_bib71","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.eururo.2023.12.015","article-title":"Transperineal versus transrectal magnetic resonance imaging-targeted and systematic prostate biopsy to prevent infectious complications: the PREVENT randomized trial","volume":"86","author":"Hu","year":"2024","journal-title":"Eur Urol"},{"issue":"5","key":"10.1016\/j.ucl.2025.09.002_bib72","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.euo.2024.01.019","article-title":"Transperineal versus transrectal magnetic resonance imaging-targeted biopsies for prostate cancer diagnosis: final results of the randomized PERFECT trial (CCAFU-PR1)","volume":"7","author":"Ploussard","year":"2024","journal-title":"Eur Urol Oncol"},{"issue":"5","key":"10.1016\/j.ucl.2025.09.002_bib73","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S1470-2045(25)00100-7","article-title":"Local anaesthetic transperineal biopsy versus transrectal prostate biopsy in prostate cancer detection (TRANSLATE): a multicentre, randomised, controlled trial","volume":"26","author":"Bryant","year":"2025","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.ucl.2025.09.002_bib74","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/JU.0000000000003788","article-title":"Complications following transrectal and transperineal prostate biopsy: results of the ProBE-PC randomized clinical trial","volume":"211","author":"Mian","year":"2024","journal-title":"J Urol"}],"container-title":["Urologic Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0094014325000850?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0094014325000850?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T14:05:49Z","timestamp":1765289149000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0094014325000850"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":75,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S0094014325000850"],"URL":"https:\/\/doi.org\/10.1016\/j.ucl.2025.09.002","relation":{},"ISSN":["0094-0143"],"issn-type":[{"type":"print","value":"0094-0143"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advances in Prostate Biopsy","name":"articletitle","label":"Article Title"},{"value":"Urologic Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ucl.2025.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}